Masaki Ri¹, Kazutaka Sunami², Morio Matsumoto³, Chihiro Shimazaki⁴, Hideki Asaoku⁵, Dai Maruyama⁶, Hirohiko Shibayama⁷, Kenichi Ishizawa⁸, Hiroyuki Takamatsu⁹, Takashi Ikeda¹⁰, Hitomi Kaneko¹¹, Michihiro Uchiyama¹², Toru Kiguchi¹³, Satoshi Iyama¹⁴, Hirokazu Murakami¹⁵, Toru Sasaki¹⁶, Keisuke Tada¹⁶, Kenshi Suzuki¹⁷, Shinsuke Iida¹ (1.Hematol. & Oncol., Nagoya City University, Nagoya, Japan, 2.National Hospital Organization Okayama Medical Center, Okayama, Japan, 3.National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan, 4.Japan Community Healthcare Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 5.Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan, 6.National Cancer Center Hospital, Tokyo, Japan, 7.Osaka University Graduate School of Medicine, Osaka, Japan, 8.Yamagata University Faculty of Medicine, Yamagata, Japan, 9.Kanazawa University Hospital, Kanazawa, Japan, 10.Shizuoka Cancer Center, Shizuoka, Japan, 11.Japanese Red Cross Osaka Hospital, Osaka, Japan, 12.Japanese Red Cross Society Suwa Hospital, Suwa, Japan, 13.Chugoku Central Hospital, Fukuyama, Japan, 14.Sapporo Medical University School of Medicine, Sapporo, Japan, 15.Gunma University Graduate School of Health Sciences, Maebashi, Japan, 16.Sanofi K.K., 17.Japanese Red Cross Medical Center, Tokyo, Japan)

Kenshi Suzuki¹, Paul G. Richardson², Michel Attal³, Jesus San-Miguel⁴, Meral Beksac⁵, Ivan Spicka⁶, Xavier Leleu⁷, Fredrik Scjesvold⁸, Philippe Moreau⁹, Meletios A. Dimopoulos¹⁰, Jeffrey_Shang-Yi Huang¹¹, Jiri Minarik¹², Michele Cavo¹³, H._Miles Prince¹⁴, Sandrine Mace¹⁵, Kathryn P. Corzo¹⁶, Frank Campana¹⁶, Solenn Le-Guennec¹⁵, Franck Dubin¹⁵, Kenneth_C. Anderson² (1.Japanese Red Cross Medical Center, Shibuya City, Tokyo, Japan, 2.Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America, 3.Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France, French Republic, 4.Clinica Universidad de Navarra, Navarra, Spain, Spain, 5.Ankara University, Ankara, Turkey, Republic of Turkey, 6.Charles University in Prague, Prague, Czech Republic, Czech Republic, 7.Hopital Claude Huriez, CHRU Lille, Lille, France, French Republic, 8.Oslo Myeloma Center, Oslo University Hospital, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway, Kingdom of Norway, 9.CHU Nantes, Nantes, France, French Republic, 10.National and Kapodistrian University of Athens, Athens, Greece, Hellenic Republic, 11.National Taiwan University Hospital, Taipei, Taiwan, Taiwan, 12.University Hospital Olomouc, Olomouc, Czech Republic, Czech Republic, 13.Univeristy of Bologna, Bologna, Italy, Italian Republic, 14.Epworth Healthcare and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia, 15.Sanofi R & D, Vitry-Alfortville, France, French Republic, 16.Sanofi-Genzyme Oncology, Cambridge, MA, United States of America)

Saori Soeda¹, Takuya Yamashita¹, Atsushi Isoda², Kazuhito Suzuki³, Toru Kiguchi⁴, Norina Tanaka⁵, Junji Tanaka⁵, Makoto Sasaki⁶, Norio Komatsu⁶, Hiroshi Yasui⁷, Yoichi Imai⁷, Jian Hua⁸, Masao Hagihara⁸, Mariko Ishibashi⁹, Koichi Inokuchi¹⁰, Yasunobu Sekiguchi¹¹, Masaaki Noguchi¹¹, Hideto Tamura¹⁰ (1.Hematology Department, Luke's International University, 2.Department of Hematology, National Hospital Organization Shibukawa Medical Center, 3.Division of Clinical Oncology/Hematology, the Jikei University Kashiwa Hospital, 4.Department of Hematology, Chugoku Central Hospital, 5.Department of Hematology, Tokyo Women's Medical University, 6.Division of Hematology, Juntendo University School of Medicine, 7.Dep Hematology/Oncology, The Institute of Medical Science, University of Tokyo, 8.Department of Hematology, Eiju General Hospital, 9.Department of Microbiology and Immunology, Nippon Medical School, 10.Department of Hematology, Nippon Medical School, 11.Department of Hematology, Juntendo University Urayasu Hospital)

Kenshi Suzuki¹, Kosei Matsue², Kazutaka Sunami³, Naoki Takezako⁴, Atsushi Shinagawa⁵, Sanae Sakurai⁶, Hiromi Tamakoshi⁶, Tsvetan Biyukov⁷, Teresa Peluso⁷, Paul G. Richardson⁸ (1.Japanese Red Cross Medical Center, 2.Kameda Medical Center, 3.National Hospital Organization Okayama Medical Center, 4.National Hospital Organization Disaster Medical Center, 5.Hitachi General Hospital, Ibaraki, Japan, 6.Celgene K.K., Japan, 7.Celgene International Sarl, 8.Dana-Farber Cancer Institute)

Masaki Ri (Nagoya City University 1)

Hiroshi Yasui¹, Arinobu Tojo¹, Jooeun Bae², Doris Peterkin³, Noopur Raje⁴, Nikhil Munshi², Anderson Kenneth² (1.Hematology/Oncology, Institute of Medical Science, Tokyo Univ., Tokyo, Japan, 2.Dana-Farber Cancer Institute, Harvard Medical School, MA, USA, 3.OncoPep Inc., MA, USA, 4.Massachusetts General Hospital Cancer Center, Harvard Medical School, MA, USA)